The bleeding time in normal subjects is mainly determined by platelet von Willebrand factor and is independent from blood group

Abstract

Bleeding time (BT) is the most important test “in vivo” evaluating the primary hemostasis. No relationship between plasma von Willebrand factor (vWF) and BT has been found in normal subjects, whereas no data are available on the relationship between platelet vWF and blood group or BT in normal subjects. To clarify the reciprocal relationship between blood group, vWF and BT, we studied 177 normal subjects. The influence of blood group on BT was analyzed in 116 subjects and the distribution of platelet and plasma vWF between different blood groups in 111 subjects. Furthermore, in a subgroup of 50 subjects, a multivariate regression model, including age, platelet count, plasma and platelet vWF:Ag and Ristocetin Cofactor (RiCof), hematocrit, sex and 0 or non-O blood group was used to assess the joint influence of these variables on BT. BT was similar in O and non-O group (P=0.310) and, although plasma vWF was significantly lower in 0 group (P<0.0001), platelet vWF content was similarly distributed (P=0.873 vWF:Ag and P=0.322 RiCof). Furthermore, platelet vWF was not correlated with plasma vWF (r=0.06, P=0.526). In the multivariate regression analysis, only platelet vWF, age and platelet count showed a significant, inverse correlation with BT (P=0.004), explaining 25% of the total variation of this test. Platelet vWF resulted therefore the main determinant of BT.